Moi Teaching and Referral Hospital was started in 1916 with a bed capacity of 60 to cater for the Africans Health Needs. It later served as a District Hospital before attaining referral status vide Legal Notice No. 98 of 12 June 1998 of the State Corporations Act.

There are 1,000 beds in Moi Teaching and Referral Hospital.

During the past decade, Moi Teaching and Referral Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moi Teaching and Referral Hospital" #1 sponsor was "AIDS Clinical Trials Group" with 5 trials, followed by "Duke University" with 5 trials sponsored, "Indiana University" with 2 trials sponsored, "University Hospital, Linkoeping" with 2 trials sponsored and "AIDS Malignancy Consortium" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moi Teaching and Referral Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials as a collaborator, "Moi Teaching and Referral Hospital" with 4 trials as a collaborator, "Fogarty International Center of the National Institute of Health" with 2 trials as a collaborator, "Indiana Clinical and Translational Sciences Institute" with 2 trials as a collaborator and "Moi Univeristy" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Moi Teaching and Referral Hospital" are "HIV-1 Infection" (4 trials), "Heart Failure" (2 trials), "Trauma" (2 trials), "AIDS-related Diffuse Large Cell Lymphoma" (1 trials) and "AIDS-related Diffuse Mixed Cell Lymphoma" (1 trials). Many other conditions were trialed in "Moi Teaching and Referral Hospital" in a lesser frequency.

Most popular intervention types in "Moi Teaching and Referral Hospital" are "Other" (8 trials), "Drug" (6 trials), "Diagnostic Test" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emtricitabine/tenofovir disoproxil fumarate" (3 trials), "Lopinavir/ritonavir" (2 trials), "Raltegravir" (2 trials), "Abacavir" (1 trials) and "Abacavir/lamivudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Moi Teaching and Referral Hospital" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Moi Teaching and Referral Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Moi Teaching and Referral Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Moi Teaching and Referral Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".